EMEA-002448-PIP01-18-M01

Table of contents

Key facts

Active substance
PEGylated-fibroblast growth factor 21 (BMS-986036)
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0387/2020
PIP number
EMEA-002448-PIP01-18-M01
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of non-alcoholic steatohepatitis (NASH)
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Bristol-Myers Squibb International Corporation

Tel. +44 1895523740
E-mail: medical.information@bms.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating